Aakash R Sheth, MD

Cardiology Fellow @UPMCHHCVFellow @HVIUPMC|Former Internal Medicine resident @LSUHS|Racket Sports and Cricket|Tech Stuff

[Udhayvir Grewal @UGrewalMD]

@StefanoByer ⭐️ soon to be PGY3 IM resident @IntMedatIowa led this important work on outcomes of patients with ATTR cardiac amyloidosis and cardiac arrhythmias. @drpaari @UIowaCVFellows

Dr Byer is applying to cardiology 🫀 fellowship this year and any program would be extremely lucky to have him. 💯

[Aakash R Sheth, MD @AakashRSheth]

@UGrewalMD @WinshipAtEmory @UIowaCancer @SagarLonialMD @KalinskyKevin @RamalingamMD Emory is lucky to have you. Congratulations my friend @UGrewalMD

[Aakash R Sheth, MD @AakashRSheth]

LBBAP compared to BiV pacing produced
1. ⬇️ composite endpoints: all-cause mortality and HFH
2. Greater ⬆️ in LVEF
3. ⬇️ arrhythmic risk

Great start but we need larger RCTs.

#LBCT #HRS2025

[Aakash R Sheth, MD @AakashRSheth]

@a_h_ghoneem @PittCardiology Thanks for the kind words @a_h_ghoneem

[Aakash R Sheth, MD @AakashRSheth]

Truly grateful for the incredible mentorship and camaraderie here @UPMCHHCVFellow It’s been an honor to learn and grow alongside such an amazing team.

[UPMC Harrisburg CV Fellowship @UPMCHHCVFellow]

Our ⭐️ third-year fellow @AakashRSheth presenting a fantastic grand rounds today on the history of atrial fibrillation management, and how we got to where we are at today.

@AakashRSheth will be joining @PittCardiology next July for his EP fellowship & we are so proud of him!

[JACC Journals @JACCJournals]

Atrioventricular node artery may arise from the right, left, or both coronary arteries, w/ variable course in inferior pyramidal space. Understanding its anatomy & variations is vital during catheter ablation or surgery to prevent arterial injury. https://t.co/6aJhBiqk1r

#JACCCaseReports #epAblation #cvImaging @shivkumarmd

[JICE @JICE_EP]

New #FreeRead Article in
@JICE_EP

Long-term Impact of Atrial Fibrillation Catheter Ablation on HF with Preserved Ejection Fraction

🧐📖https://t.co/ItN0aZgbAe

by @harsh_cardio, Rezwan Munshi, @AakashRSheth, @SidAgarwalMBBS, Freddy Del-Carpio Munoz, Guru Kowlgi, @DrDeese99, Mohamed Rafa Labedi, Sourbha Dani & @abhishek_mbbs

#EPeeps

[Aakash R Sheth, MD @AakashRSheth]

@UGrewalMD 🙏🏼too kind! Thank you my friend

[Aakash R Sheth, MD @AakashRSheth]

I am thrilled to announce that I will be continuing my training as an Electrophysiology Fellow at UPMC Presbyterian-Shadyside @PittCardiology @HviUpmc.

I am deeply grateful to my mentors and friends at @UPMCHHCVFellow for their guidance and support along the way!

[UPMC Harrisburg CV Fellowship @UPMCHHCVFellow]

Super excited to meet our new fellows in July! #match #ACCFIT
@alexbgcvd @atizaz

[Aakash R Sheth, MD @AakashRSheth]

Twitter used to be one of the most efficient ways to connect within the #MedTwitter #EPeeps community.

Restrictions on DM without being forced to be a verified/paid customer of Twitter (unfortunately called “X”now) is one of the many reasons to switch to @bluesky .

[Aakash R Sheth, MD @AakashRSheth]

@UGrewalMD @SabarishMD @UIowaCancer @SpringerNature @GrerkS @NicoleFleege @IHC_guy @drpaari @nihardesai7 @emouMD @momilhem @meburkard @gkirkpatrick7 @BuzickJustin Amazing work @UGrewalMD Very proud of you. Future rockstar Heme Onc attending!

[Henry Han @HanCardiomd]

#AFib ablation in end-stage HF : Lessons from CASTLE-HTx

📍In end-stage HF pt with AF, catheter ablation reduced AF burden by 36.3 pts & improved LVEF from 29.2% to 39.1% at 12 months (p < 0.001)

📍Persistent AF also dropped significantly (34.8% vs baseline; p = 0.0001).

https://t.co/PvzdDJKnrW
@ESC_Journals #EJHF @EJHFEiC
#Ablation #HeartFailure

[Aakash R Sheth, MD @AakashRSheth]

Finally got to meet and learn from @JonHsuMD at Watchman Fellows Fall Forum. Thank you @BSCCardiology and @BiltmoreHotel Miami for hosting us.

[CircEP @CirculationEP]

In this multicenter study, intravascular hemolysis affected 94.3% of patients after PFA, with the highest severity occurring above 54 PFA deliveries #AHAJournals #Epeeps @SergeBoveda @dogi84md @CaluoriGuido https://t.co/Cd2m6oQMJJ

[Allen Amorn MD @AllenAmornMD]

Very important work. So many patients don’t get optimal imaging because of fear of adverse events with CIEDs. We need @HRSonline @Cardiology to advocate for changes to CIED and MRI labeling. MagnaSafe registry is over a decade old now with no changes in federal law!

[Aakash R Sheth, MD @AakashRSheth]

Future superstar NET specialist and dear friend @UGrewalMD writes about the adverse events associated with Lutathera!! Should be an excellent read for all NET enthusiasts!

[Udhayvir Grewal @UGrewalMD]

🔥Hot off the press-
Happy to share our real world post-marketing pharmacovigilance analysis on hematological toxicities (focus on MDS/AML) with Lutathera (Lu177-DOTA-TATE) in 🇺🇸 .
👉🏽Post-marketing surveillance data from the @US_FDA (2018-2023)
👉🏽 3443 adverse events, 243 (7.1%) were hematologic
👉🏽 majority thrombocytopenia, leukopenia, anemia and pancytopenia
👉🏽 MDS & AML comprised 2% of the reported events each.
👉🏽For context we compare the reporting of hematological toxicities (esp MDS and AML) with topoisomerase inhibitors
👉🏽This is a helpful reference that may potentially inform discussions with patients planning to receive PRRT (now referred to as radioligand therapy or RLT).
Limitations- captures only 🇺🇸 data and the events reported to @US_FDA.
Thank you @thakre_anuj for your help with the project.
Link- https://t.co/0b8dJSTtEq

[Aakash R Sheth, MD @AakashRSheth]

From getting countless opportunities to learn and network to having a great platform to present our team’s work @HRSonline #HRS24 never disappoints. #epeeps

@harsh_cardio @UPMCHHCVFellow @HviUpmc @abhishek_mbbs @drpaari @SaurabhSDani @DrDeese99 @TheRhythmDoc @MLabedi

[Aakash R Sheth, MD @AakashRSheth]

Thanks Dr. Dominic!!

[Aakash R Sheth, MD @AakashRSheth]

We will presenting our work on the impact of #GLP1RA in post-AF ablation patients at #HRS24 on Sunday, May 19. Here is the @CardiologyToday article covering our research.

@harsh_cardio @SaurabhSDani @abhishek_mbbs @DrDeese99 @TheRhythmDoc @drpaari @UPMCHHCVFellow @HviUpmc

[Cardiology Today @CardiologyToday]

In patients with type 2 diabetes who underwent ablation for #afib, those taking a GLP-1 receptor agonist had lower risk for AF recurrence, mortality and other outcomes #HRS2024 @HRSonline @AakashRSheth @HviUpmc #Cardiotwitter #EPeeps

Read more👇
https://t.co/GxvgpvtE6R

[Aakash R Sheth, MD @AakashRSheth]

@UGrewalMD @HeartRhythmTV Thanks a lot! @UGrewalMD